Cases 1 - 10 of 51
In Re: Restasis (Cyclosporine
as 20-1603
Respondent:
MSP Recovery Claims, Series LLC, Self Insured Schools of California, on behalf of itself and all others similarly situated, Walgreen Co. and others
Petitioner:
Allergan Inc.
Houston Home Dialysis LP v. Blue Cross and Blue Shield of Alabama et al
as 2:2019cv01765
Defendant:
Excellus Health Plan, Inc. d/b/a Excellus BlueCross BlueShield, Anthem Health Plans Inc, National Account Service Company, LLC and others
Plaintiff:
Houston Home Dialysis LP
Cause Of Action: 15 U.S.C. § 15
Houston Home Dialysis LP v. Blue Cross and Blue Shield of Alabama et al
as 4:2019cv03791
Defendant:
Excellus Health Plan, Inc. d/b/a Excellus BlueCross BlueShield, HealthNow New York, Inc., Anthem Health Plans of Kentucky, Inc. d/b/a Anthem Blue Cross and Blue Shield of Kentucky and others
Plaintiff:
Houston Home Dialysis and Houston Home Dialysis LP
Cause Of Action: 15 U.S.C. § 15
Caldwell v. Blue Cross and Blue Shield of Alabama et al
as 2:2019cv00565
Defendant:
Caring for Montannans, Inc., BlueCross BlueShield of Mississippi, Blue Cross and Blue Shield of Georgia, Inc. and others
Plaintiff:
Matthew B Caldwell
Cause Of Action: 15 U.S.C. § 1
Louisiana Health Services and Indemnity Company et al v. Ranbaxy, Inc. et al
as 1:2019cv10274
Defendant:
Ranbaxy, USA, Inc., Ranbaxy Laboratories, LTD, Sun Pharmaceutical Industries Ltd. and others
Plaintiff:
HMO Louisiana, Inc. and Louisiana Health Services and Indemnity Company
Cause Of Action: 18 U.S.C. § 1961
In Re: Ranbaxy Generic Drug Application Antitrust Litigation
as 1:2019md02878
In Re:
Ranbaxy Generic Drug Application Antitrust Litigation
Plaintiff:
Meijer, Inc., Meijer Distribution, Inc., Cesar Castillo, Inc. and others
Defendant:
Ranbaxy Laboratories Limited, Sun Pharmaceutical Industries Limited, Ranbaxy, Inc. and others
Consolidated Plaintiff:
United Food and Commercial Workers Health and Welfare Fund of Northern Pennsylvania and Louisiana Health Services and Indemnity Company d/b/a Blue Cross and Blue Shield of Louisiana
Respondent:
Prinston Pharmaceutical Inc.
Interested Party:
Novartis Pharmaceuticals Corporation and Astrazeneca Pharmaceuticals L.P.
Not Classified By Court:
Winifred Weitsen
Cause Of Action: 18 U.S.C. § 1962 Racketeering (RICO) Act
Louisiana Health Service and Indemnity Company, et al v. Allergan, Inc.
as 1:2018cv01430
Plaintiff:
HMO Louisiana, Inc, Louisiana Health Service and Indemnity Company and Louisiana Health Service and Indemnity Company on behalf of itself and all others similarly situated doing business as Blue Cross Blue Shield Of Louisiana
Defendant:
Allergan, Inc.
Cause Of Action: 15 U.S.C. § 25 Clayton Act
Louisiana Health Service and Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana and HMO Louisiana, Inc v. Allergan, Inc.
as 3:2018cv00185
Defendant:
Allergan, Inc.
Plaintiff:
Louisiana Health Service and Indemnity Company d/b/a Blue Cross Blue Shield of Louisiana and HMO Louisiana, Inc
Cause Of Action: 15 U.S.C. § 25 Clayton Act
Louisiana Health Service and Indemnity Company, et al v. Allergan, Inc.
as 3:2018cv00186
Defendant:
Allergan, Inc.
Plaintiff:
HMO Louisiana, Inc and Louisiana Health Service and Indemnity Company
Cause Of Action: 15 U.S.C. § 25 Clayton Act
In Re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation
as 1:2018md02819
Defendant:
Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation
Plaintiff:
Allergan, Inc., 1199SEIU Greater New York Benefit Fund, 1199SEIU Licensed Practical Nurses Welfare Fund and others
In Re:
In Re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation
Interested Party:
Mylan Pharmaceuticals, Inc. and Teva Pharmaceuticals USA, Inc.
Petitioner:
Akorn Inc.
Cause Of Action: 15 U.S.C. § 2 Antitrust Litigation
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
